- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
BioXcel Therapeutics (NASDAQ:BTAI), Quotes and News Summary
BioXcel Therapeutics (NASDAQ: BTAI)
Earnings
see more| FY 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-12-20 | ||||||
| REV | |||||||
| FY 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-11-09 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
BioXcel Therapeutics Questions & Answers
You can purchase shares of BioXcel Therapeutics (NASDAQ: BTAI) through any online brokerage.
Other companies in BioXcel Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Centessa Pharmaceuticals (NASDAQ:CNTA), Eagle Pharmaceuticals (NASDAQ:EGRX), Tango Therapeutics (NASDAQ:TNGX) and Mesoblast (NASDAQ:MESO).
The latest price target for BioXcel Therapeutics (NASDAQ: BTAI) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting BTAI to fall to within 12 months (a possible -74.42% downside). 50 analyst firms have reported ratings in the last year.
The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $15.64 last updated August 12, 2022, 8:00 PM UTC.
The next BioXcel Therapeutics (BTAI) dividend date is projected to be Thursday, September 1, 2022.
BioXcel Therapeutics’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for BioXcel Therapeutics.
BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.